Table 5.

Comparison of adverse events between UPS and non-UPS in combined group.

Adverse Event	No. (%) Adverse Events by Treatment		P
	UPS	non-UPS
myelosuppression	20 (20/28, 71.4%)	37 (37/56, 66.1%)	0.620
gastrointestinal reactions	19 (19/28, 67.9%)	36 (36/56, 64.3%)	0.746
abnormal liver function	18 (18/28, 64.3%)	33 (33/56, 58.9%)	0.636
pigmentation	5 (5/28, 17.9%)	16 (16/56, 28.6%)	0.285
arrhythmia	6 (6/28, 21.4%)	14 (14/56, 25.0%)	0.717
allergies	3 (3/28, 10.7%)	8 (8/56, 14.3%)	0.909
renal inadequacy	1 (1/28, 3.6%)	5 (5/56, 8.9%)	0.653